Resultado da Busca
David Earl Nichols (born December 23, 1944, Covington, Kentucky) is an American pharmacologist and medicinal chemist. Previously the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology at Purdue University, Nichols has worked in the field of psychoactive drugs since 1969.
12 de jan. de 2024 · Dr. David E. Nichols is one of the world’s leading experts in the field of psychedelic pharmacology. He’s a Professor Emeritus of Pharmacology at Purdue University and the co-founder of the Heffter Research Institute.
- 1944-Present
- Pharmacology Professor
- American
2017. Effects of Schedule I drug laws on neuroscience research and treatment innovation. DJ Nutt, LA King, DE Nichols. Nature Reviews Neuroscience 14 (8), 577-585. , 2013. 392. 2013. Effects of enantiomers of MDA, MDMA and related analogues on [3H] serotonin and [3H] dopamine release from superfused rat brain slices.
Professor Emeritus of Pharmacology. E-mail: drdave@purdue.edu. Specialization: Medicinal and Bioorganic Chemistry; Molecular Pharmacology and Toxicology. Education. B.S. - 1969 - University of Cincinnati. Ph.D. - 1973 - University of Iowa. Postdoc - 1973-74 -University of Iowa. Research.
Dr. David E. Nichols is Professor Emeritus of Pharmacology at Purdue University and an Adjunct Professor at the University of North Carolina at Chapel Hill. He is also Chairman of the Board and a Co-Founder of the Heffter Research Institute.
Psychedelics (serotonergic hallucinogens) are powerful psychoactive substances that alter perception and mood and affect numerous cognitive processes. They are generally considered physiologically safe and do not lead to dependence or addiction.
David Earl Nichols (born December 23, 1944, Covington, Kentucky) is an American pharmacologist and medicinal chemist. Previously the Robert C. and Charlotte P. Anderson Distinguished Chair in Pharmacology at Purdue University, Nichols has worked in the field of psychoactive drugs and psychedelics research since 1969.
